Every material Form 8-K Exponent has filed with the SEC since February 07, 2024, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Exponent reported third-quarter 2026 total revenues up 18% to $173.7 million and net income of $30.9 million, or $0.64 per diluted share, compared with $0.55 a year earlier. The company raised its full-year 2026 revenue and margin guidance and declared a $0.31 quarterly dividend payable December 18, 2026.
Revenues before reimbursements rose 12% to $153.1 million; EBITDA was $45.0 million, or 29.4% of those revenues.
Full-year 2026 outlook: revenues before reimbursements to grow 10% to 11%, and EBITDA to be 28.0% to 28.3% of revenues before reimbursements.
Fourth-quarter 2026 outlook: revenues before reimbursements to grow 8% to 10%, and EBITDA to be 26.3% to 26.8% of revenues before reimbursements.
Quarterly cash dividend of $0.31 per share, with a record date of December 4, 2026 and payment on December 18, 2026.
Exponent reported second-quarter 2026 results for the quarter ended July 3, 2026, with total revenues up 21% to $171.6 million and net income up to $29.4 million, or $0.60 per diluted share, from $0.52 a year earlier. The company raised its full-year 2026 revenue growth and EBITDA margin guidance and declared a $0.31 quarterly dividend and an additional $50 million share repurchase authorization.
Q2 revenues before reimbursements rose 12% to $148.9 million; net income was $29.4 million, or $0.60 per diluted share, versus $26.6 million, or $0.52, in Q2 2025.
Full-year 2026 guidance raised: revenues before reimbursements to grow 9% to 10%, and EBITDA to be 27.8% to 28.1% of revenues before reimbursements.
Third-quarter 2026 outlook: revenues before reimbursements expected to grow 8% to 10%, with EBITDA at 28.0% to 28.5% of revenues before reimbursements.
Quarterly dividend of $0.31 per share is payable September 18, 2026, to holders of record as of September 4, 2026; the buyback authorization was increased by $50 million.
Exponent reported first-quarter fiscal 2026 results with total revenues up 14% to $166.3 million and net income up to $29.6 million, or $0.59 per diluted share, from $0.52 a year earlier. The company maintained its full-year 2026 guidance and set a quarterly dividend of $0.31 per share, while its Board added $50 million to the share repurchase authorization.
Revenues before reimbursements rose 10% to $151.8 million; total revenues rose 14% to $166.3 million.
Net income was $29.6 million, or $0.59 per diluted share, versus $26.7 million, or $0.52, a year earlier.
EBITDA rose to $43.1 million, or 28.4% of net revenues, from $37.5 million, or 27.3%.
Dividend of $0.31 per share is payable June 18, 2026 to holders of record as of June 5, 2026; $17.7 million remained for repurchases as of April 3, 2026, before the $50 million increase.
Exponent, Inc. (EXPO) said its board appointed John Pye, Ph.D., as President and Eric Anderson as Chief Financial Officer, both effective May 1, 2026, and both will report to CEO Catherine Corrigan. Current CFO Richard Schlenker will remain Executive Vice President and has been nominated for election to the board, while director Paul Johnston retires and Karen Richardson becomes Chairman at the June 4, 2026 annual meeting.
John Pye, who joined the company in 1999 and is currently Vice President of Global Offices and Innovation, becomes President effective May 1, 2026, with a base salary of $650,000 and a stock option grant covering 21,000 shares.
Eric Anderson, Vice President of Finance and Accounting since 2024 and a company employee since 2003, becomes Chief Financial Officer effective May 1, 2026, with a base salary of $525,000 and a stock option grant covering 12,600 shares.
Richard Schlenker stops being Chief Financial Officer on May 1, 2026, stays on as Executive Vice President, and has been nominated to stand for election to the board.
Paul Johnston retires from the board at the Annual Meeting of Stockholders on June 4, 2026, and Karen Richardson, the Lead Independent Director, will then become Chairman.
Exponent reported fourth-quarter 2025 revenue up 7.8% to $147.4 million and net income of $24.8 million, or $0.49 per diluted share, versus $0.46 a year earlier. For fiscal 2025, net income fell to $106.0 million, or $2.07 per diluted share, from $109.0 million, or $2.11, even as revenue rose 4.2%, and the company expects high-single-digit revenue growth in fiscal 2026. The board also raised the quarterly dividend from $0.30 to $0.31 per share.
Q4 2025 total revenues rose 7.8% to $147.4 million; the quarter had 13 weeks versus 14 weeks in Q4 2024.
Fiscal 2025 net income was $106.0 million, or $2.07 per diluted share, versus $109.0 million, or $2.11, in fiscal 2024.
For fiscal 2026, Exponent expects revenues before reimbursements to grow in the high-single digits, with EBITDA of 27.6% to 28.1% of revenues before reimbursements.
Quarterly dividend increased from $0.30 to $0.31 per share, payable March 20, 2026, to holders of record as of March 6, 2026.
Exponent reported third-quarter 2025 revenue of $147.1 million, up 8% from a year earlier, and net income of $28.0 million, or $0.55 per diluted share, up from $0.50. The company maintained its full-year revenue outlook, raised its full-year EBITDA margin outlook, and its board declared a $0.30 quarterly dividend and added $100 million to its share repurchase authorization. Nine-month net income and diluted EPS still declined from 2024.
Q3 2025 revenue was $147.1 million, up 8% from $136.3 million; revenues before reimbursements rose 10% to $137.1 million.
Q3 2025 net income was $28.0 million, or $0.55 per diluted share, versus $26.0 million, or $0.50, in Q3 2024.
Nine-month net income fell to $81.2 million, or $1.58 per diluted share, from $85.4 million, or $1.66, a year earlier.
Board declared a $0.30 quarterly dividend payable December 19, 2025 to holders of record December 5, 2025, and added $100 million to the repurchase authority, on top of $21.6 million available as of October 3, 2025.
Exponent reported second quarter 2025 revenues before reimbursements of $132.9 million, approximately flat year over year, and total revenues up 1% to $142.0 million. Net income fell to $26.6 million, or $0.52 per diluted share, from $29.2 million, or $0.57, a year earlier, and the company kept its full-year 2025 guidance while declaring a $0.30 quarterly dividend.
Revenues before reimbursements were $132.9 million, approximately flat versus $132.4 million in Q2 2024; total revenues rose 1% to $142.0 million.
Net income was $26.6 million, or $0.52 per diluted share, versus $29.2 million, or $0.57 per diluted share, in Q2 2024.
Full-year 2025 guidance was maintained: revenues before reimbursements expected to grow in the low single digits, and EBITDA expected at 26.50% to 27.0% of revenues before reimbursements.
Board declared a quarterly cash dividend of $0.30 per share, payable September 19, 2025, to stockholders of record as of September 5, 2025.
Exponent reported first-quarter 2025 revenue of $145.5 million, roughly flat from a year earlier, but net income fell to $26.7 million, or $0.52 per diluted share, from $30.1 million, or $0.59, a year earlier. The company kept its full-year 2025 guidance but expects second-quarter revenues before reimbursements to fall in the low-single digits, and it declared a $0.30 quarterly dividend.
Q1 2025 revenues before reimbursements were $137.4 million, compared with $137.2 million in Q1 2024
Net income was $26.7 million, or $0.52 per diluted share, versus $30.1 million, or $0.59, a year earlier; EBITDA fell to $37.5 million from $40.1 million
For Q2 2025, the company expects revenues before reimbursements to decline in the low-single digits, and full-year 2025 revenues before reimbursements to grow in the low-single digits
Board declared a quarterly cash dividend of $0.30 per share, payable June 20, 2025 to holders of record as of June 6, 2025
Exponent reported fourth-quarter 2024 total revenues of $136.8 million, up 11.3%, and net income of $23.6 million, or $0.46 per diluted share, versus $0.41 a year earlier. The company also raised its quarterly cash dividend from $0.28 to $0.30 per share and guided to first-quarter 2025 revenues down in the low-single digits and full-year 2025 revenues growing in the low-single digits.
Q4 2024 total revenues rose 11.3% to $136.8 million; net income rose to $23.6 million, or $0.46 per diluted share, from $20.9 million, or $0.41
Quarterly dividend increased from $0.28 to $0.30 per share, payable March 21, 2025 to holders of record as of March 7, 2025
Q1 2025 guidance: revenues before reimbursements down in the low-single digits; EBITDA 25.0% to 26.0% of revenues before reimbursements
Full-year 2025 guidance: revenues before reimbursements to grow in the low-single digits; EBITDA 26.25% to 27.0%
Exponent, Inc. disclosed that Eric Guyer, Ph.D., tendered his resignation on October 28, 2024, from his role as Group Vice President, effective November 8, 2024. The filing describes a named executive officer departure and does not state a successor or any financial effect.
Eric Guyer, Ph.D. tendered his resignation on October 28, 2024
Resignation is effective November 8, 2024
Role: Group Vice President of Exponent, Inc.
Filing identifies Guyer as a named executive officer and does not name a replacement
Exponent reported third-quarter 2024 net income of $26.0 million, or $0.50 per diluted share, up from $24.5 million, or $0.48, a year earlier, while revenues before reimbursements were roughly flat at $125.1 million. The company kept its full-year revenue growth outlook and raised its full-year EBITDA margin outlook to 27.9% to 28.1%, and it also declared a $0.28 quarterly dividend payable December 20, 2024.
Q3 2024 net income $26.0 million, or $0.50 per diluted share, vs. $24.5 million, or $0.48, in Q3 2023
Q3 revenues before reimbursements $125.1 million, roughly flat vs. $125.0 million a year earlier
Full-year 2024 guidance: revenues before reimbursements to grow in the low to mid-single digits; EBITDA margin raised to 27.9% to 28.1%
Quarterly dividend of $0.28 per share, payable December 20, 2024, to holders of record as of December 6, 2024
Exponent reported second-quarter 2024 net income of $29.2 million, up 14% from a year earlier, and revenues before reimbursements of $132.4 million, up 2%. The company raised its full-year 2024 revenue and EBITDA margin guidance and declared a $0.28 per share quarterly dividend payable September 20, 2024. Third-quarter revenues before reimbursements are expected to be approximately flat.
Q2 2024 net income rose to $29.2 million, or $0.57 per diluted share, from $25.7 million, or $0.50, in Q2 2023
Revenues before reimbursements rose 2% to $132.4 million; total revenues were approximately flat at $140.5 million
Full-year 2024 guidance raised: revenues before reimbursements to grow in the low to mid-single digits, EBITDA margin of 27.5% to 28.0%
Quarterly dividend of $0.28 per share to be paid September 20, 2024, to holders of record as of September 6, 2024
Exponent agreed to extend its commercial land lease with the State of Arizona for 15 years starting January 17, 2028, under a notice of election received June 19, 2024. Annual rent stays at $1,009,000 until January 16, 2028, then rises to approximately $6,183,000 per year, with consumer price index adjustments in 2033 and 2038. The filing adds a long-term lease obligation that shareholders should weigh against the company's future costs.
Lease extension notice received June 19, 2024; extension term of 15 years begins January 17, 2028
Annual rent is $1,009,000 until January 16, 2028
Annual rent rises to approximately $6,183,000 from January 17, 2028, with consumer price index adjustments in 2033 and 2038
Exponent reported first-quarter 2024 revenues before reimbursements up 6.6% to $137.2 million and diluted earnings per share of $0.59, up from $0.56 a year earlier. The company raised its fiscal 2024 revenue and EBITDA margin guidance and declared a $0.28 quarterly dividend payable June 21, 2024.
Q1 2024 net income was $30.1 million, or $0.59 per diluted share, versus $29.1 million, or $0.56, in Q1 2023.
Fiscal 2024 guidance raised: revenues before reimbursements expected to grow in the low-single digits, and EBITDA expected at 26.25% to 27.0% of revenues before reimbursements.
Q2 2024 outlook: revenues before reimbursements flat to up in the low-single digits, and EBITDA at 27.25% to 28.25%.
Quarterly cash dividend of $0.28 per share, payable June 21, 2024 to holders of record as of June 7, 2024.
Exponent, Inc. appointed Brian Kundert as its Chief Human Resources Officer, effective March 16, 2024, according to a Form 8-K filed March 1, 2024. Mr. Kundert joined the company in July 2023 as Vice President, Human Resources, and previously spent 19 years at Arcadis. The filing describes a routine senior executive appointment that does not include financial results or guidance.
Brian Kundert appointed Chief Human Resources Officer on February 26, 2024, effective March 16, 2024
Mr. Kundert, 49, joined Exponent on July 10, 2023 as Vice President, Human Resources
Previously Global Director of Human Resources for the Resilience division at Arcadis, where he worked for 19 years
Exponent, Inc. said on February 2, 2024 that Chief Human Resources Officer Sally Shepard will retire, effective March 15, 2024. The 8-K describes this as a named executive officer resignation and does not name a successor or give a reason for the departure.
Sally Shepard is retiring as Chief Human Resources Officer.
Retirement is effective March 15, 2024.
Exponent announced the change on February 2, 2024; the 8-K was filed February 7, 2024.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Exponent filing is on SEC EDGAR ↗. 8-K briefs of other companies →